Sinomenine synergistically enhances 5-Fu anticancer effects in oral cancer through modulating the miR-140-5p-PDK1-anaerobic glycolysis pathway
Food and Chemical Toxicology · 2025
DOI: 10.1016/j.fct.2025.115385 ↗Kurz gefasst
Fachartikel in der Zeitschrift Food and Chemical Toxicology, 2025. Verfasst von Dongmei Wang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Comprehensive Treatment Clinic, The First Medical Center of the PLA General Hospital, Beijing, 100039, China. Hauptthemen laut MEDLINE: MicroRNAs, Morphinans, Glycolysis, Fluorouracil. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 35 Literaturangaben.
Abstract (Originalsprache)
Oral squamous cell carcinoma (OSCC) is a type of human malignancy with a high mortality rate worldwide. Sinomenine (SIN), an active component of sinomenium acutum, has shown potential antitumor activities in various types of cancers. This study discovered that the combination of 5-Fu and SIN treatments had synergistic inhibitory effects on OSCC cells (CI < 1). Moreover, miRNA-140-5p was significantly downregulated in OSCC tumors and cell lines. Treatment with sinomenine upregulated miR-140-5p and suppressed anaerobic glycolysis of OSCC cells. We established a 5-Fu resistant OSCC cell line (CAL33 5-Fu R), which showed elevated anaerobic glycolysis and downregulated miR-140-5p. Through western blot, luciferase assay, and rescue experiments, we identified the pyruvate dehydrogenase kinase 1 (PDK1), a key enzyme in anaerobic glycolysis, as a direct target of miR-140-5p, overexpression of which led to anaerobic glycolysis suppression and 5-Fu sensitization in OSCC cells. Furthermore, blocking the SIN-induced miR-140-5p successfully overcame the SIN-inhibited anaerobic glycolysis and 5-Fu resistance in OSCC cells. Meaningfully, results from in vivo mice xenograft experiments validated that sinomenine enhanced anti-cancer effects of 5-Fu treatment. Our findings reveal that the combination of sinomenine and 5-Fu synergistically enhances the cytotoxicity of OSCC cells by regulating the miR-140-5p-PDK1 axis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Comprehensive Treatment Clinic, The First Medical Center of the PLA General Hospital, Beijing, 100039, China.
- Department of Spinal Surgery, The Fourth Medical Center of the PLA General Hospital, Beijing, 100048, China.
- Department of Diagnostic Radiology, The First Medical Center of the PLA General Hospital, Beijing, 100039, China.
- Comprehensive Treatment Clinic, The First Medical Center of the PLA General Hospital, Beijing, 100039, China. Electronic address: wenyixi1213@163.com.
Zitieren
APA
Wang, D., Wang, R., Sun, H., & Wen, Z. (2025). Sinomenine synergistically enhances 5-Fu anticancer effects in oral cancer through modulating the miR-140-5p-PDK1-anaerobic glycolysis pathway. Food and Chemical Toxicology. https://doi.org/10.1016/j.fct.2025.115385
Vancouver
Wang D, Wang R, Sun H, Wen Z. Sinomenine synergistically enhances 5-Fu anticancer effects in oral cancer through modulating the miR-140-5p-PDK1-anaerobic glycolysis pathway. Food and Chemical Toxicology. 2025. doi:10.1016/j.fct.2025.115385
BibTeX
@article{Wang2025,
author = {Wang, Dongmei and Wang, Rui and Sun, Hui and Wen, Zhi},
title = {Sinomenine synergistically enhances 5-Fu anticancer effects in oral cancer through modulating the miR-140-5p-PDK1-anaerobic glycolysis pathway},
journal = {Food and Chemical Toxicology},
year = {2025},
doi = {10.1016/j.fct.2025.115385}
}
EUVIMED